Physical  ||| S:0 E:9 ||| JJ
function  ||| S:9 E:18 ||| NN
interfering  ||| S:18 E:30 ||| NN
with  ||| S:30 E:35 ||| IN
pain  ||| S:35 E:40 ||| NN
and  ||| S:40 E:44 ||| CC
symptoms  ||| S:44 E:53 ||| NNS
in  ||| S:53 E:56 ||| IN
fibromyalgia  ||| S:56 E:69 ||| JJ
patients  ||| S:69 E:78 ||| NNS
The  ||| S:78 E:82 ||| DT
aim  ||| S:82 E:86 ||| NN
of  ||| S:86 E:89 ||| IN
this  ||| S:89 E:94 ||| DT
study  ||| S:94 E:100 ||| NN
was  ||| S:100 E:104 ||| VBD
to  ||| S:104 E:107 ||| TO
assess  ||| S:107 E:114 ||| VB
the  ||| S:114 E:118 ||| DT
relationship  ||| S:118 E:131 ||| NN
between  ||| S:131 E:139 ||| IN
variables  ||| S:139 E:149 ||| NNS
of  ||| S:149 E:152 ||| IN
physical  ||| S:152 E:161 ||| JJ
assessment  ||| S:161 E:172 ||| NN
-  ||| S:172 E:174 ||| :
muscular  ||| S:174 E:183 ||| JJ
strength ||| S:183 E:191 ||| NN
,  ||| S:191 E:193 ||| ,
flexibility  ||| S:193 E:205 ||| NN
and  ||| S:205 E:209 ||| CC
dynamic  ||| S:209 E:217 ||| JJ
balance  ||| S:217 E:225 ||| NN
-  ||| S:225 E:227 ||| :
with  ||| S:227 E:232 ||| IN
pain ||| S:232 E:236 ||| NN
,  ||| S:236 E:238 ||| ,
pain  ||| S:238 E:243 ||| NN
threshold ||| S:243 E:252 ||| NN
,  ||| S:252 E:254 ||| ,
and  ||| S:254 E:258 ||| CC
fibromyalgia  ||| S:258 E:271 ||| JJ
symptoms  ||| S:271 E:280 ||| NNS
( ||| S:280 E:281 ||| -LRB-
FM ||| S:281 E:283 ||| NNP
) ||| S:283 E:284 ||| -RRB-
.  ||| S:284 E:286 ||| .
Our  ||| S:286 E:290 ||| PRP$
sample  ||| S:290 E:297 ||| NN
consists  ||| S:297 E:306 ||| VBZ
of  ||| S:306 E:309 ||| IN
55  ||| S:309 E:312 ||| CD
women ||| S:312 E:317 ||| NNS
,  ||| S:317 E:319 ||| ,
with  ||| S:319 E:324 ||| IN
age  ||| S:324 E:328 ||| NN
ranging  ||| S:328 E:336 ||| VBG
from  ||| S:336 E:341 ||| IN
30  ||| S:341 E:344 ||| CD
to  ||| S:344 E:347 ||| TO
55  ||| S:347 E:350 ||| CD
years  ||| S:350 E:356 ||| NNS
( ||| S:356 E:357 ||| -LRB-
mean  ||| S:357 E:362 ||| VB
of  ||| S:362 E:365 ||| IN
46.5 ||| S:365 E:369 ||| CD
,  ||| S:369 E:371 ||| ,
( ||| S:371 E:372 ||| -LRB-
standard  ||| S:372 E:381 ||| JJ
deviation ||| S:381 E:390 ||| NN
,  ||| S:390 E:392 ||| ,
SD=6.6 ||| S:392 E:398 ||| CD
) ||| S:398 E:399 ||| -RRB-
) ||| S:399 E:400 ||| -RRB-
,  ||| S:400 E:402 ||| ,
mean  ||| S:402 E:407 ||| JJ
body  ||| S:407 E:412 ||| NN
mass  ||| S:412 E:417 ||| NN
index  ||| S:417 E:423 ||| NN
( ||| S:423 E:424 ||| -LRB-
BMI ||| S:424 E:427 ||| NNP
)  ||| S:427 E:429 ||| -RRB-
of  ||| S:429 E:432 ||| IN
28.7  ||| S:432 E:437 ||| CD
( ||| S:437 E:438 ||| -LRB-
3.8 ||| S:438 E:441 ||| CD
)  ||| S:441 E:443 ||| -RRB-
and  ||| S:443 E:447 ||| CC
diagnosed  ||| S:447 E:457 ||| VBN
for  ||| S:457 E:461 ||| IN
FM  ||| S:461 E:464 ||| NNP
according  ||| S:464 E:474 ||| VBG
to  ||| S:474 E:477 ||| TO
the  ||| S:477 E:481 ||| DT
American  ||| S:481 E:490 ||| NNP
College  ||| S:490 E:498 ||| NNP
of  ||| S:498 E:501 ||| IN
Rheumatology  ||| S:501 E:514 ||| NNP
criteria ||| S:514 E:522 ||| NNS
.  ||| S:522 E:524 ||| .
Pain  ||| S:524 E:529 ||| NN
intensity  ||| S:529 E:539 ||| NN
was  ||| S:539 E:543 ||| VBD
measured  ||| S:543 E:552 ||| VBN
using  ||| S:552 E:558 ||| VBG
a  ||| S:558 E:560 ||| DT
visual  ||| S:560 E:567 ||| JJ
analogue  ||| S:567 E:576 ||| JJ
scale  ||| S:576 E:582 ||| NN
( ||| S:582 E:583 ||| -LRB-
VAS ||| S:583 E:586 ||| NNP
)  ||| S:586 E:588 ||| -RRB-
and  ||| S:588 E:592 ||| CC
pain  ||| S:592 E:597 ||| NN
threshold  ||| S:597 E:607 ||| NN
( ||| S:607 E:608 ||| -LRB-
PT ||| S:608 E:610 ||| NNP
)  ||| S:610 E:612 ||| -RRB-
using  ||| S:612 E:618 ||| VBG
Fisher ||| S:618 E:624 ||| NNP
's  ||| S:624 E:627 ||| POS
dolorimeter ||| S:627 E:638 ||| NN
.  ||| S:638 E:640 ||| .
FM  ||| S:640 E:643 ||| NNP
symptoms  ||| S:643 E:652 ||| NNS
were  ||| S:652 E:657 ||| VBD
assessed  ||| S:657 E:666 ||| VBN
by  ||| S:666 E:669 ||| IN
the  ||| S:669 E:673 ||| DT
Fibromyalgia  ||| S:673 E:686 ||| NNP
Impact  ||| S:686 E:693 ||| NNP
Questionnaire  ||| S:693 E:707 ||| NNP
( ||| S:707 E:708 ||| -LRB-
FIQ ||| S:708 E:711 ||| NNP
) ||| S:711 E:712 ||| -RRB-
;  ||| S:712 E:714 ||| :
flexibility  ||| S:714 E:726 ||| NN
by  ||| S:726 E:729 ||| IN
the  ||| S:729 E:733 ||| DT
third  ||| S:733 E:739 ||| JJ
finger  ||| S:739 E:746 ||| NN
to  ||| S:746 E:749 ||| TO
floor  ||| S:749 E:755 ||| NN
test  ||| S:755 E:760 ||| NN
( ||| S:760 E:761 ||| -LRB-
3FF ||| S:761 E:764 ||| NNP
) ||| S:764 E:765 ||| -RRB-
;  ||| S:765 E:767 ||| :
the  ||| S:767 E:771 ||| DT
muscular  ||| S:771 E:780 ||| JJ
strength  ||| S:780 E:789 ||| NN
index  ||| S:789 E:795 ||| NN
( ||| S:795 E:796 ||| -LRB-
MSI ||| S:796 E:799 ||| NNP
)  ||| S:799 E:801 ||| -RRB-
by  ||| S:801 E:804 ||| IN
the  ||| S:804 E:808 ||| DT
maximum  ||| S:808 E:816 ||| JJ
volunteer  ||| S:816 E:826 ||| NN
isometric  ||| S:826 E:836 ||| NN
contraction  ||| S:836 E:848 ||| NN
at  ||| S:848 E:851 ||| IN
flexion  ||| S:851 E:859 ||| NN
and  ||| S:859 E:863 ||| CC
extension  ||| S:863 E:873 ||| NN
of  ||| S:873 E:876 ||| IN
right  ||| S:876 E:882 ||| JJ
knee  ||| S:882 E:887 ||| NN
and  ||| S:887 E:891 ||| CC
elbow  ||| S:891 E:897 ||| VBP
using  ||| S:897 E:903 ||| VBG
a  ||| S:903 E:905 ||| DT
force  ||| S:905 E:911 ||| NN
transducer ||| S:911 E:921 ||| NN
,  ||| S:921 E:923 ||| ,
dynamic  ||| S:923 E:931 ||| JJ
balance  ||| S:931 E:939 ||| NN
by  ||| S:939 E:942 ||| IN
the  ||| S:942 E:946 ||| DT
time  ||| S:946 E:951 ||| NN
to  ||| S:951 E:954 ||| TO
get  ||| S:954 E:958 ||| VB
up  ||| S:958 E:961 ||| RP
and  ||| S:961 E:965 ||| CC
go  ||| S:965 E:968 ||| VB
( ||| S:968 E:969 ||| -LRB-
TUG ||| S:969 E:972 ||| NNP
)  ||| S:972 E:974 ||| -RRB-
test  ||| S:974 E:979 ||| NN
and  ||| S:979 E:983 ||| CC
the  ||| S:983 E:987 ||| DT
functional  ||| S:987 E:998 ||| JJ
reach  ||| S:998 E:1004 ||| NN
test  ||| S:1004 E:1009 ||| NN
( ||| S:1009 E:1010 ||| -LRB-
FRT ||| S:1010 E:1013 ||| NNP
) ||| S:1013 E:1014 ||| -RRB-
.  ||| S:1014 E:1016 ||| .
Data  ||| S:1016 E:1021 ||| NNP
were  ||| S:1021 E:1026 ||| VBD
analysed  ||| S:1026 E:1035 ||| VBN
using  ||| S:1035 E:1041 ||| VBG
Pearson ||| S:1041 E:1048 ||| NNP
's  ||| S:1048 E:1051 ||| POS
correlation ||| S:1051 E:1062 ||| NN
,  ||| S:1062 E:1064 ||| ,
as  ||| S:1064 E:1067 ||| RB
well  ||| S:1067 E:1072 ||| RB
as  ||| S:1072 E:1075 ||| IN
simple  ||| S:1075 E:1082 ||| JJ
and  ||| S:1082 E:1086 ||| CC
multivariate  ||| S:1086 E:1099 ||| JJ
regression  ||| S:1099 E:1110 ||| JJ
tests ||| S:1110 E:1115 ||| NNS
,  ||| S:1115 E:1117 ||| ,
with  ||| S:1117 E:1122 ||| IN
significance  ||| S:1122 E:1135 ||| NN
level  ||| S:1135 E:1141 ||| NN
of  ||| S:1141 E:1144 ||| IN
5 ||| S:1144 E:1145 ||| CD
% ||| S:1145 E:1146 ||| NN
.  ||| S:1146 E:1148 ||| .
PT  ||| S:1148 E:1151 ||| NNP
and  ||| S:1151 E:1155 ||| CC
FIQ  ||| S:1155 E:1159 ||| NNP
were  ||| S:1159 E:1164 ||| VBD
weakly  ||| S:1164 E:1171 ||| JJ
but  ||| S:1171 E:1175 ||| CC
significantly  ||| S:1175 E:1189 ||| RB
correlated  ||| S:1189 E:1200 ||| VBN
with  ||| S:1200 E:1205 ||| IN
the  ||| S:1205 E:1209 ||| DT
TUG ||| S:1209 E:1212 ||| NNP
,  ||| S:1212 E:1214 ||| ,
MSI  ||| S:1214 E:1218 ||| NNP
and  ||| S:1218 E:1222 ||| CC
3FF  ||| S:1222 E:1226 ||| CD
as  ||| S:1226 E:1229 ||| IN
well  ||| S:1229 E:1234 ||| RB
as  ||| S:1234 E:1237 ||| IN
VAS  ||| S:1237 E:1241 ||| NNP
with  ||| S:1241 E:1246 ||| IN
the  ||| S:1246 E:1250 ||| DT
TUG  ||| S:1250 E:1254 ||| NNP
and  ||| S:1254 E:1258 ||| CC
MSI  ||| S:1258 E:1262 ||| NNP
( ||| S:1262 E:1263 ||| -LRB-
p  ||| S:1263 E:1264 ||| CD
< ||| S:1264 E:1265 ||| SYM
0.05 ||| S:1265 E:1269 ||| CD
) ||| S:1269 E:1270 ||| -RRB-
.  ||| S:1270 E:1272 ||| .
VAS ||| S:1272 E:1275 ||| NNP
,  ||| S:1275 E:1277 ||| ,
PT  ||| S:1277 E:1280 ||| NNP
and  ||| S:1280 E:1284 ||| CC
FIQ  ||| S:1284 E:1288 ||| NNP
was  ||| S:1288 E:1292 ||| VBD
not  ||| S:1292 E:1296 ||| RB
correlated  ||| S:1296 E:1307 ||| VBN
with  ||| S:1307 E:1312 ||| IN
FRT ||| S:1312 E:1315 ||| NNP
.  ||| S:1315 E:1317 ||| .
Simple  ||| S:1317 E:1324 ||| JJ
regression  ||| S:1324 E:1335 ||| NN
suggests  ||| S:1335 E:1344 ||| VBZ
that ||| S:1344 E:1348 ||| IN
,  ||| S:1348 E:1350 ||| ,
alone ||| S:1350 E:1355 ||| RB
,  ||| S:1355 E:1357 ||| ,
TUG ||| S:1357 E:1360 ||| NNP
,  ||| S:1360 E:1362 ||| ,
FR ||| S:1362 E:1364 ||| NNP
,  ||| S:1364 E:1366 ||| ,
MSI  ||| S:1366 E:1370 ||| NNP
and  ||| S:1370 E:1374 ||| CC
3FF  ||| S:1374 E:1378 ||| NNP
are  ||| S:1378 E:1382 ||| VBP
low  ||| S:1382 E:1386 ||| JJ
predictors  ||| S:1386 E:1397 ||| NN
of  ||| S:1397 E:1400 ||| IN
VAS ||| S:1400 E:1403 ||| NNP
,  ||| S:1403 E:1405 ||| ,
PT  ||| S:1405 E:1408 ||| NNP
and  ||| S:1408 E:1412 ||| CC
FIQ ||| S:1412 E:1415 ||| NNP
.  ||| S:1415 E:1417 ||| .
For  ||| S:1417 E:1421 ||| IN
the  ||| S:1421 E:1425 ||| DT
VAS ||| S:1425 E:1428 ||| NNP
,  ||| S:1428 E:1430 ||| ,
the  ||| S:1430 E:1434 ||| DT
best  ||| S:1434 E:1439 ||| RBS
predictive  ||| S:1439 E:1450 ||| JJ
model  ||| S:1450 E:1456 ||| NN
includes  ||| S:1456 E:1465 ||| VBZ
TUG  ||| S:1465 E:1469 ||| NNP
and  ||| S:1469 E:1473 ||| CC
MSI ||| S:1473 E:1476 ||| NNP
,  ||| S:1476 E:1478 ||| ,
explaining  ||| S:1478 E:1489 ||| VBG
12.6 ||| S:1489 E:1493 ||| CD
%  ||| S:1493 E:1495 ||| NN
of  ||| S:1495 E:1498 ||| IN
pain  ||| S:1498 E:1503 ||| NN
variability ||| S:1503 E:1514 ||| NN
.  ||| S:1514 E:1516 ||| .
For  ||| S:1516 E:1520 ||| IN
TP  ||| S:1520 E:1523 ||| NNP
and  ||| S:1523 E:1527 ||| CC
total  ||| S:1527 E:1533 ||| JJ
symptoms ||| S:1533 E:1541 ||| NNS
,  ||| S:1541 E:1543 ||| ,
as  ||| S:1543 E:1546 ||| RB
obtained  ||| S:1546 E:1555 ||| VBN
by  ||| S:1555 E:1558 ||| IN
the  ||| S:1558 E:1562 ||| DT
FIQ ||| S:1562 E:1565 ||| NNP
,  ||| S:1565 E:1567 ||| ,
most  ||| S:1567 E:1572 ||| RBS
predictive  ||| S:1572 E:1583 ||| JJ
model  ||| S:1583 E:1589 ||| NN
includes  ||| S:1589 E:1598 ||| VBZ
3FF  ||| S:1598 E:1602 ||| NNP
and  ||| S:1602 E:1606 ||| CC
MSI ||| S:1606 E:1609 ||| NNP
,  ||| S:1609 E:1611 ||| ,
which  ||| S:1611 E:1617 ||| WDT
respectively  ||| S:1617 E:1630 ||| RB
respond  ||| S:1630 E:1638 ||| VB
by  ||| S:1638 E:1641 ||| IN
30 ||| S:1641 E:1643 ||| CD
%  ||| S:1643 E:1645 ||| NN
and  ||| S:1645 E:1649 ||| CC
21 ||| S:1649 E:1651 ||| CD
%  ||| S:1651 E:1653 ||| NN
of  ||| S:1653 E:1656 ||| IN
the  ||| S:1656 E:1660 ||| DT
variability ||| S:1660 E:1671 ||| NN
.  ||| S:1671 E:1673 ||| .
Muscular  ||| S:1673 E:1682 ||| JJ
strength ||| S:1682 E:1690 ||| NN
,  ||| S:1690 E:1692 ||| ,
flexibility  ||| S:1692 E:1704 ||| NN
and  ||| S:1704 E:1708 ||| CC
balance  ||| S:1708 E:1716 ||| NN
are  ||| S:1716 E:1720 ||| VBP
associated  ||| S:1720 E:1731 ||| VBN
with  ||| S:1731 E:1736 ||| IN
pain ||| S:1736 E:1740 ||| NN
,  ||| S:1740 E:1742 ||| ,
pain  ||| S:1742 E:1747 ||| NN
threshold ||| S:1747 E:1756 ||| NN
,  ||| S:1756 E:1758 ||| ,
and  ||| S:1758 E:1762 ||| CC
symptoms  ||| S:1762 E:1771 ||| NNS
in  ||| S:1771 E:1774 ||| IN
FM  ||| S:1774 E:1777 ||| JJ
patients ||| S:1777 E:1785 ||| NNS
.  ||| S:1785 E:1787 ||| .
